Literature DB >> 17657595

Low dose lipid formulations: effects on gastric emptying and biliary secretion.

Greg A Kossena1, William N Charman, Clive G Wilson, Bridget O'Mahony, Blythe Lindsay, John M Hempenstall, Christopher L Davison, Patrick J Crowley, Christopher J H Porter.   

Abstract

PURPOSE: Food stimulates changes to gastrointestinal secretion and motility patterns, however, the effect of smaller quantities of lipid, such as that contained in a lipid-based drug formulation, has not been detailed. This study aimed to examine the effects of small quantities of lipid on gastric emptying and biliary secretion.
METHODS: The influence of oral administration of three lipid-based formulations and a negative control formulation on gastric emptying and biliary secretion was evaluated in 16 healthy male subjects using gamma scintigraphy, ultrasonography and duodenal aspiration.
RESULTS: Low quantities (2 g) of long chain lipid stimulated gall bladder contraction and elevated intestinal bile salt, phospholipid and cholesterol levels. Changes in gastric emptying were also evident, although these did not reach statistical significance. Administration of a similar quantity of medium chain lipid, however, had little effect on gastric emptying and gallbladder contraction and did not stimulate appreciable increases in intestinal concentrations of biliary-derived lipids.
CONCLUSIONS: The quantities of long chain lipid that might be administered in a pharmaceutical formulation stimulate gallbladder contraction and elevate intestinal levels of bile salt and phospholipid. This effect is a likely contributor to the ability of lipid based formulations to enhance the absorption of poorly water-soluble drugs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17657595     DOI: 10.1007/s11095-007-9363-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  50 in total

Review 1.  Food-drug interactions.

Authors:  Lars E Schmidt; Kim Dalhoff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Gastric emptying and intragastric distribution of oil in the presence of a liquid or a solid meal.

Authors:  M Edelbroek; M Horowitz; A Maddox; J Bellen
Journal:  J Nucl Med       Date:  1992-07       Impact factor: 10.057

3.  Apolipoprotein A-IV acts in the brain to inhibit gastric emptying in the rat.

Authors:  T Okumura; K Fukagawa; P Tso; I L Taylor; T N Pappas
Journal:  Am J Physiol       Date:  1996-01

4.  Temporal relationships of cholecystokinin release, pancreatobiliary secretion, and gastric emptying of a mixed meal.

Authors:  M Fried; E A Mayer; J B Jansen; C B Lamers; I L Taylor; S R Bloom; J H Meyer
Journal:  Gastroenterology       Date:  1988-11       Impact factor: 22.682

5.  Gastric emptying rates of drug preparations. II. Effects of size and density of enteric-coated drug preparations and food on gastric emptying rates in humans.

Authors:  N Kaniwa; N Aoyagi; H Ogata; A Ejima; H Motoyama; H Yasumi
Journal:  J Pharmacobiodyn       Date:  1988-08

Review 6.  Gastrointestinal afferents as targets of novel drugs for the treatment of functional bowel disorders and visceral pain.

Authors:  P Holzer
Journal:  Eur J Pharmacol       Date:  2001-10-19       Impact factor: 4.432

7.  Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs.

Authors:  Greg A Kossena; Ben J Boyd; Christopher J H Porter; William N Charman
Journal:  J Pharm Sci       Date:  2003-03       Impact factor: 3.534

8.  The effect of oleic acid on the human ileal brake and its implications for small intestinal transit of tablet formulations.

Authors:  C L Dobson; S S Davis; S Chauhan; R A Sparrow; I R Wilding
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

9.  Postprandial gallbladder motor function: refilling and turnover of bile in health and in cholelithiasis.

Authors:  R P Jazrawi; P Pazzi; M L Petroni; N Prandini; C Paul; J A Adam; S Gullini; T C Northfield
Journal:  Gastroenterology       Date:  1995-08       Impact factor: 22.682

10.  Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine.

Authors:  Christopher J H Porter; Ann Marie Kaukonen; Agnes Taillardat-Bertschinger; Ben J Boyd; Jacquelyn M O'Connor; Glenn A Edwards; William N Charman
Journal:  J Pharm Sci       Date:  2004-05       Impact factor: 3.534

View more
  19 in total

1.  Bioavailability of cinnarizine in dogs: effect of SNEDDS loading level and correlation with cinnarizine solubilization during in vitro lipolysis.

Authors:  Anne T Larsen; Pernilla Åkesson; Anna Juréus; Lasse Saaby; Ragheb Abu-Rmaileh; Bertil Abrahamsson; Jesper Østergaard; Anette Müllertz
Journal:  Pharm Res       Date:  2013-08-15       Impact factor: 4.200

Review 2.  Lipids in the Stomach - Implications for the Evaluation of Food Effects on Oral Drug Absorption.

Authors:  Mirko Koziolek; Frédéric Carrière; Christopher J H Porter
Journal:  Pharm Res       Date:  2018-02-08       Impact factor: 4.200

Review 3.  Lipid-based formulations and drug supersaturation: harnessing the unique benefits of the lipid digestion/absorption pathway.

Authors:  Hywel D Williams; Natalie L Trevaskis; Yan Yan Yeap; Mette U Anby; Colin W Pouton; Christopher J H Porter
Journal:  Pharm Res       Date:  2013-07-04       Impact factor: 4.200

Review 4.  Simulation Models for Prediction of Bioavailability of Medicinal Drugs-the Interface Between Experiment and Computation.

Authors:  Mahmoud E Soliman; Adeniyi T Adewumi; Oluwole B Akawa; Temitayo I Subair; Felix O Okunlola; Oluwayimika E Akinsuku; Shahzeb Khan
Journal:  AAPS PharmSciTech       Date:  2022-03-15       Impact factor: 3.246

Review 5.  Characterising lipid lipolysis and its implication in lipid-based formulation development.

Authors:  Nicky Thomas; René Holm; Thomas Rades; Anette Müllertz
Journal:  AAPS J       Date:  2012-09-07       Impact factor: 4.009

6.  Supersaturated-Silica Lipid Hybrids Improve in Vitro Solubilization of Abiraterone Acetate.

Authors:  Hayley B Schultz; Paul Joyce; Nicky Thomas; Clive A Prestidge
Journal:  Pharm Res       Date:  2020-03-31       Impact factor: 4.200

7.  Food effects on the formulation, dosing, and administration of cannabidiol (CBD) in humans: A systematic review of clinical studies.

Authors:  Lucy H Silmore; Andrew R Willmer; Edmund V Capparelli; Gus R Rosania
Journal:  Pharmacotherapy       Date:  2021-03-18       Impact factor: 4.705

8.  Evaluating the potential of cubosomal nanoparticles for oral delivery of amphotericin B in treating fungal infection.

Authors:  Zhiwen Yang; Meiwan Chen; Muhua Yang; Jian Chen; Weijun Fang; Ping Xu
Journal:  Int J Nanomedicine       Date:  2014-01-06

9.  SNEDDS Containing Poorly Water Soluble Cinnarizine; Development and in Vitro Characterization of Dispersion, Digestion and Solubilization.

Authors:  Anne T Larsen; Anayo Ogbonna; Ragheb Abu-Rmaileh; Bertil Abrahamsson; Jesper Ostergaard; Anette Müllertz
Journal:  Pharmaceutics       Date:  2012-12-14       Impact factor: 6.321

10.  The role of lipid-based nano delivery systems on oral bioavailability enhancement of fenofibrate, a BCS II drug: comparison with fast-release formulations.

Authors:  Tengfei Weng; Jianping Qi; Yi Lu; Kai Wang; Zhiqiang Tian; Kaili Hu; Zongning Yin; Wei Wu
Journal:  J Nanobiotechnology       Date:  2014-09-24       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.